Whether a Minimal Volume Could Predict Fluid Responsiveness Using Thermodilution by PAC in Septic Shock Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04515511 |
|
Recruitment Status :
Recruiting
First Posted : August 17, 2020
Last Update Posted : September 3, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Septic Shock Hemodynamic Instability Fluid Therapy | Other: 4% gelatin | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 50 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Diagnostic |
| Official Title: | Medical Intensive Care Unit of PUMCH |
| Actual Study Start Date : | July 1, 2019 |
| Actual Primary Completion Date : | August 1, 2020 |
| Estimated Study Completion Date : | September 2022 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: standard care
ICU septic shock patients with refractory hypotension with indwelling pulmonary artery catheter received five sequential intravenous boluses of 100 mL 4% gelatin. Cardiac output measured by thermodilution of PAC before fluid challenge (baseline) and three minutes after each bolus. Fluid responsiveness (FR) was defined as an increase in CO greater than 10% after 500 mL fluid infusion. The smallest volume which can perform an effective fluid challenge was analyzed.
|
Other: 4% gelatin
Pulmonary artery catheter insertion is prepared before fluid challenge. Baseline hemodynamic value and each time after 5 sequential intravenous boluses of 100 mL colloid are recorded.
Other Name: Pulmonary artery catheter |
- Cardiac output [ Time Frame: Baseline and immediately after each bolus of 100 mL colloid, average 3 minutes ]Cardiac output measured by therm-dilution of pulmonary artery catheter. An increase in cardiac output(CO) greater than 10% after a volume expansion of 500 mL is defined as fluid responsiveness(FR).
- Oxygen saturation [ Time Frame: Baseline and immediately after each bolus of 100 mL colloid, average 3 minutes ]Oxygen saturation can be obtained directly from blood gas include which reflects extraction of oxygen and assess whether CO is sufficient enough to meet patient's enough.
- Carbon dioxide partial pressure [ Time Frame: Baseline and immediately after each bolus of 100 mL colloid, average 3 minutes ]PCO2 can be obtained directly from blood gas. It is considered as alternative markers of tissue hypoperfusion and attempted to be used to guide treatment for shock.
- Hemoglobin [ Time Frame: Baseline and immediately after each bolus of 100 mL colloid, average 3 minutes ]Hemoglobin will be diluted during fluid challenge and it is also an important index to guide fluid resuscitation by improving extraction of oxygen and optimizing oxygen delivery.
- Heart rate [ Time Frame: Baseline and immediately after each bolus of 100 mL colloid, average 1 minutes ]Heart rate is monitored to assess the effect of the fluid challenge
- Mean arterial pressure [ Time Frame: Baseline and immediately after each bolus of 100 mL colloid, average 1 minutes ]Mean arterial pressure is monitored to assess the effect of the fluid challenge
- Central venous pressure [ Time Frame: Baseline and immediately after each bolus of 100 mL colloid, average 1 minutes ]Central venous pressure is monitored to assess the preload status and effect of the fluid challenge
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients diagnosis of septic shock and is required fluid challenge in the presence of invasive hemodynamic monitoring.
- Patients with hypotension (SBP <90 mmHg or MAP <65 mmHg)
- Patients with evidences of tissue hypoperfusion (including but not limited to oliguria, skin mottling, altered mental status, cool peripheries, hyperlactatemia, et al).
Exclusion Criteria:
- Age less than 18yrs or greater than 80yrs
- Shock is diagnosed with other types of shock
- Known allergy to colloid fluids
- Pregnancy
- Recent participation in another biomedical study.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04515511
| Contact: Li Weng, Professor | +8618600017819 | wengli@gmail.com | |
| Contact: Du Bin, Professor | +8615601348897 | dubin98@gmail.com |
| China, Beijing | |
| Li Weng | Recruiting |
| Beijing, Beijing, China, 100102 | |
| Contact: Li Weng, professor 15601348897 wengli@gmail.com | |
| Contact: Bin Du, professor +8618600017819 dubin98@gmail.com | |
| Responsible Party: | Peking Union Medical College Hospital |
| ClinicalTrials.gov Identifier: | NCT04515511 |
| Other Study ID Numbers: |
PUMCH fc |
| First Posted: | August 17, 2020 Key Record Dates |
| Last Update Posted: | September 3, 2020 |
| Last Verified: | August 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Plan Description: | In our department, we has done a serial clinical studies of fluid challenge, we will do retrospective study first. |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Sepsis/Septic shock Hemodynamic monitor Fluid challenge |
Cardiac output Pulmonary artery catheter Thermodilution |
|
Shock, Septic Shock Pathologic Processes Sepsis |
Infections Systemic Inflammatory Response Syndrome Inflammation |

